Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression

• Main Authors: Sng, Ming Keat, Chan, Jeremy Soon Kiat, Teo, Ziqiang, Phua, Terri, Tan, Eddie Han Pin, Wee, Jonathan Wei Kiat, Koh, Nikki Jun Ning, Tan, Chek Kun, Chen, Jia Peng, Pal, Mintu, Tong, Benny Meng Kiat, Tnay, Ya Lin, Ng, Xuan Rui, Zhu, Pengcheng, Chiba, Shunsuke, Wang, Xiaomeng, Wahli, Walter, Tan, Nguan Soon
• Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
• Format: Article
• Language: English
• Published: 2018
• Subjects: Selective Deletion; Dermal Fibrosis
• Online Access: https://hdl.handle.net/10356/86650; http://hdl.handle.net/10220/45278
• Institution: Nanyang Technological University

Connective tissue diseases of the skin are characterized by excessive collagen deposition in the skin and internal organs. Fibroblasts play a pivotal role in the clinical presentation of these conditions. Nuclear receptor peroxisome-proliferator activated receptors (PPARs) are therapeutic targets for dermal fibrosis, but the contribution of the different PPAR subtypes are poorly understood. Particularly, the role of fibroblast PPARβ/δ in dermal fibrosis has not been elucidated. Thus, we generated a mouse strain with selective deletion of PPARβ/δ in the fibroblast (FSPCre-Pparb/d−/−) and interrogated its epidermal and dermal transcriptome profiles. We uncovered a downregulated gene, leucine-rich alpha-2-glycoprotein-1 (Lrg1), of previously unknown function in skin development and architecture. Our findings suggest that the regulation of Lrg1 by PPARβ/δ in fibroblasts is an important signaling conduit integrating PPARβ/δ and TGFβ1-signaling networks in skin health and disease. Thus, the FSPCre-Pparb/d−/− mouse model could serve as a novel tool in the current gunnery of animal models to better understand dermal fibrosis.